Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2a
Clinical trial NCT03719313 · COMPLETED
Trial details
- NCT number
- NCT03719313
- Sponsor
- Eiger BioPharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-01
- Primary completion
- 2022-10-06
- Enrollment
- 407
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.